Literature DB >> 12079401

Increased expression and redistribution of the antiapoptotic molecule Bcl-xL in Parkinson's disease.

Andreas Hartmann1, Annick Mouatt-Prigent, Miquel Vila, Nacer Abbas, Céline Perier, Baptiste A Faucheux, Sheela Vyas, Etienne C Hirsch.   

Abstract

In the present study, we tried to clarify the potentially protective role of Bcl-x(L), an anti-apoptotic member of the Bcl-2 family of proteins, in Parkinson's disease (PD). Using in situ hybridization on human postmortem mesencephalon sections, we show that in PD patients Bcl-x(L) mRNA expression per dopaminergic neuron was almost double that of controls. We also show that, ultrastructurally, this effect may be mediated by a redistribution of Bcl-x(L) from the cytosol to the outer mitochondrial membrane. 2002 Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12079401     DOI: 10.1006/nbdi.2002.0494

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  9 in total

1.  Differential nigral expression of bcl-2 protein family in the pure and common forms of Dementia with Lewy bodies: relevance for dopaminergic neuronal vulnerability.

Authors:  M Saldaña; E Aguilar; M Bonastre; C Marin
Journal:  J Neural Transm (Vienna)       Date:  2007-07-04       Impact factor: 3.575

2.  Effect of cholestasis and NeuroAid treatment on the expression of Bax, Bcl-2, Pgc-1α and Tfam genes involved in apoptosis and mitochondrial biogenesis in the striatum of male rats.

Authors:  Mohammad Nasehi; Sepehr Torabinejad; Mehrdad Hashemi; Salar Vaseghi; Mohammad-Reza Zarrindast
Journal:  Metab Brain Dis       Date:  2019-11-26       Impact factor: 3.584

Review 3.  Demystifying the Neuroprotective Role of Neuropeptides in Parkinson's Disease: A Newfangled and Eloquent Therapeutic Perspective.

Authors:  Tapan Behl; Piyush Madaan; Aayush Sehgal; Sukhbir Singh; Hafiz A Makeen; Mohammed Albratty; Hassan A Alhazmi; Abdulkarim M Meraya; Simona Bungau
Journal:  Int J Mol Sci       Date:  2022-04-20       Impact factor: 6.208

Review 4.  Programmed cell death in Parkinson's disease.

Authors:  Katerina Venderova; David S Park
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

5.  Effect of Buspirone, Fluoxetine and 8-OH-DPAT on Striatal Expression of Bax, Caspase-3 and Bcl-2 Proteins in 6-Hydroxydopamine-Induced Hemi-Parkinsonian Rats.

Authors:  Hamdollah Sharifi; Alireza Mohajjel Nayebi; Safar Farajnia; Rasool Haddadi
Journal:  Adv Pharm Bull       Date:  2015-11-30

6.  Postmortem studies in Parkinson's disease.

Authors:  Andreas Hartmann
Journal:  Dialogues Clin Neurosci       Date:  2004-09       Impact factor: 5.986

7.  Protective effects of kidney-tonifying Chinese herbal preparation on substantia nigra neurons in a mouse model of Parkinson's disease.

Authors:  Jing Cai; Yun Tian; Ruhui Lin; Xuzheng Chen; Zhizhen Liu; Jindong Xie
Journal:  Neural Regen Res       Date:  2012-02-25       Impact factor: 5.135

Review 8.  Nutritional Regulators of Bcl-xL in the Brain.

Authors:  Han-A Park; Katheryn Broman; Allison Stumpf; Sara Kazyak; Elizabeth A Jonas
Journal:  Molecules       Date:  2018-11-19       Impact factor: 4.411

Review 9.  Neuroglial Senescence, α-Synucleinopathy, and the Therapeutic Potential of Senolytics in Parkinson's Disease.

Authors:  Sean J Miller; Cameron E Campbell; Helen A Jimenez-Corea; Guan-Hui Wu; Robert Logan
Journal:  Front Neurosci       Date:  2022-04-19       Impact factor: 5.152

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.